ClouDr Group Limited (9955.HK) stock price, financials & research

Regular session · HKT · Market data may be delayed.

Company profile

ClouDr Group Limited operates as an investment holding company, providing a diverse range of services within the healthcare sector. The firm supplies hospitals and pharmacies with crucial medical products, including devices like blood glucose meters and vital sign monitors, glucose testing strips, and both over-the-counter and prescription drugs. In addition to physical goods, ClouDr delivers software-as-a-service (SaaS) platforms tailored for healthcare facilities and pharmacies, while also offering digital marketing solutions to pharmaceutical companies. Furthermore, the company facilitates the management of chronic conditions through real-time online consultations, digital health monitoring, and remote prescription and ordering services. Established in 2014, ClouDr Group Limited maintains its primary corporate office in Hangzhou, China.

Industry: Medical - Distribution
Sector: Healthcare
Headquarters: CN
CEO: Ming Kuang
Listed since: Jul 6, 2022
Employees: 887

Market position

Day range

Current HK$0.51

HK$0.50HK$0.52

52-week range

Current HK$0.51

HK$0.46HK$1.77

Open: HK$0.50
Previous close: HK$0.51
Volume: 201.8K; 0.78× average
Average volume: 258.48K; Average daily volume
Market cap: 329.32M HKD
Beta: 0.3; Market reference 1
50-day average: HK$0.532; -4.14% below average
200-day average: HK$0.7698; -33.74% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM): -0.29×
P/B (TTM): 0.5×
P/S (TTM): 0.17×
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 47.75%
Operating margin: -52.57%
Net margin: -56.93%

Financial health

Debt / equity: 0.53×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

1.62B HKD-53.47%

Operating income

−853.3M HKD-126.86%

Net income

−924.15M HKD-78.96%

Metric (HKD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.62B HKD	3.49B HKD	3.69B HKD	2.99B HKD	1.76B HKD
Cost of goods sold	848.1M HKD	2.63B HKD	2.78B HKD	2.2B HKD	1.19B HKD
Gross profit	775.08M HKD	861.67M HKD	909.38M HKD	792.1M HKD	570.02M HKD
Research and development	46.96M HKD	75.4M HKD	88.04M HKD	114.79M HKD	236.24M HKD
Selling, general, and administrative	1.02B HKD	1.04B HKD	1.17B HKD	1.27B HKD	1.06B HKD
Operating expenses	1.63B HKD	1.24B HKD	1.22B HKD	1.38B HKD	1.27B HKD
Interest income	2.59M HKD	905K HKD	2.06M HKD	3.64M HKD	12.93M HKD
Interest expense	13.98M HKD	15.45M HKD	10.78M HKD	8.02M HKD	74.68M HKD
Depreciation and amortization	84.15M HKD	101.54M HKD	108.18M HKD	101.94M HKD	86.54M HKD
Operating income	−853.3M HKD	−376.14M HKD	−314.24M HKD	−591.56M HKD	−695.91M HKD
Net income	−924.15M HKD	−516.41M HKD	−323.07M HKD	−1.69B HKD	−4.14B HKD